Predicting Aggressive Behavior in Nonfunctional Pancreatic Neuroendocrine Tumors With Emphasis on Tumor Size Significance and Survival Trends: A Population-Based Analysis of 1787 Patients

被引:18
作者
Fathi, Amir H. [1 ]
Romanyshyn, Jonathan [1 ]
Barati, Mehdi [2 ]
Choudhury, Uzair [1 ]
Chen, Allen [1 ]
Sosa, Julie Ann [3 ]
机构
[1] Univ Calif San Francisco, Dept Surg, Fresno Med Educ Program, 2335 E Kashian Lane,Suite 220, Fresno, CA 93701 USA
[2] Univ Southern Mississippi, Hattiesburg, MS 39406 USA
[3] Univ Calif San Francisco, Dept Surg, San Francisco, CA 93701 USA
关键词
pancreatic neuroendocrine tumor; surgery; overall survival; PROGNOSTIC-FACTORS; MALIGNANCY; NEOPLASMS; PROPOSAL; PNETS;
D O I
10.1177/0003134820919730
中图分类号
R61 [外科手术学];
学科分类号
摘要
Background: Nonfunctional pancreatic neuroendocrine tumors (NF-PNETs) are rare tumors with continued controversies in management. This study aims to identify demographic and clinicopathologic characteristics associated with aggressive behavior and survival. Methods: The Surveillance, Epidemiology, and End Results database was used to identify patients with NF-PNETs from 1988 to 2012. Multivariate regression analysis and Cox proportional hazards modeling were used to assess the impact of patient, tumor, and treatment characteristics on tumor behavior and overall survival. Results: In 1787 patients identified, size was a major determinant of aggressive behavior. The probability of aggressiveness increased 100% for tumor size >= 2 cm. For tumors >= 2 cm, every I -cm increase in size was associated with an increase in probability of aggressive behavior by 11.3%. Patient age, tumor grade, and surgical resection were independent predictors of survival. Surgical resection was associated with improved survival but not grade I or II tumors with size <2 cm. Discussion: Patient age, tumor size, and grade should be in the decision-making process around the surgical management of NF-PNETs. For tumors <= 2 cm with histologic grades of I or II, the probability of aggressive behavior is low, and surgical resection does not appear to afford survival benefit. Therefore, close observation could be justified.
引用
收藏
页码:458 / 466
页数:9
相关论文
共 28 条
[1]   Tumor size correlates with malignancy in nonfunctioning pancreatic endocrine tumor [J].
Bettini, Rossella ;
Partelli, Stefano ;
Boninsegna, Letizia ;
Capelli, Paola ;
Crippa, Stefano ;
Pederzoli, Paolo ;
Scarpa, Aldo ;
Falconi, Massimo .
SURGERY, 2011, 150 (01) :75-82
[2]   Prognostic score predicting survival after resection of pancreatic neuroendocrine tumors - Analysis of 3851 patients [J].
Bilimoria, Karl Y. ;
Talamonti, Mark S. ;
Tomlinson, James S. ;
Stewart, Andrew K. ;
Winchester, David P. ;
Ko, Clifford Y. ;
Bentrem, David J. .
ANNALS OF SURGERY, 2008, 247 (03) :490-500
[3]   Clinicopathologic features and treatment trends of pancreatic neuroendocrine tumors: Analysis of 9,821 patients [J].
Bilimoria, Karl Y. ;
Tomlinson, James S. ;
Merkow, Ryan P. ;
Stewart, Andrew K. ;
Ko, Clifford Y. ;
Talamonti, Mark S. ;
Bentrem, David J. .
JOURNAL OF GASTROINTESTINAL SURGERY, 2007, 11 (11) :1460-1467
[4]   Predicting patient survival after pancreaticoduodenectomy for malignancy: histopathological criteria based on perineural infiltration and lymphovascular invasion [J].
Chen, John W. C. ;
Bhandari, Mayank ;
Astill, David S. ;
Wilson, Thomas G. ;
Kow, Lilian ;
Brooke-Smith, Mark ;
Toouli, James ;
Padbury, Robert T. A. .
HPB, 2010, 12 (02) :101-108
[5]   Predicting aggressive behavior in nonfunctioning pancreatic neuroendocrine tumors [J].
Cherenfant, Jovenel ;
Stocker, Susan J. ;
Gage, Mistry K. ;
Du, Hongyan ;
Thurow, Tiffany A. ;
Odeleye, Melanie ;
Schimpke, Scott W. ;
Kaul, Karen L. ;
Hall, Curtis R. ;
Lamzabi, Ihab ;
Gattuso, Paolo ;
Winchester, David J. ;
Marsh, Robert W. ;
Roggin, Kevin K. ;
Bentrem, David J. ;
Baker, Marshall S. ;
Prinz, Richard A. ;
Talamonti, Mark S. .
SURGERY, 2013, 154 (04) :785-791
[6]  
ERIKSSON B, 1990, CANCER-AM CANCER SOC, V65, P1883, DOI 10.1002/1097-0142(19900501)65:9<1883::AID-CNCR2820650902>3.0.CO
[7]  
2-3
[8]   ENETS Consensus Guidelines Update for the Management of Patients with Functional Pancreatic Neuroendocrine Tumors and Non-Functional Pancreatic Neuroendocrine Tumors [J].
Falconi, M. ;
Eriksson, B. ;
Kaltsas, G. ;
Bartsch, D. K. ;
Capdevila, J. ;
Caplin, M. ;
Kos-Kudla, B. ;
Kwekkeboom, D. ;
Rindi, G. ;
Kloeppel, G. ;
Reed, N. ;
Kianmanesh, R. ;
Jensen, R. T. .
NEUROENDOCRINOLOGY, 2016, 103 (02) :153-171
[9]   Non-functional Neuroendocrine Carcinoma of the Pancreas: Incidence, Tumor Biology, and Outcomes in 2,158 Patients [J].
Franko, Jan ;
Feng, Wentao ;
Yip, Linwah ;
Genovese, Elizabeth ;
Moser, A. James .
JOURNAL OF GASTROINTESTINAL SURGERY, 2010, 14 (03) :541-548
[10]   Impact of Extent of Surgery on Survival in Patients with Small Nonfunctional Pancreatic Neuroendocrine Tumors in the United States [J].
Gratian, Lauren ;
Pura, John ;
Dinan, Michaela ;
Roman, Sanziana ;
Reed, Shelby ;
Sosa, Julie Ann .
ANNALS OF SURGICAL ONCOLOGY, 2014, 21 (11) :3515-3521